Search for Clinical Trial Results

Common Variable Immunodeficiency - 36 Studies Found
Status | Study |
Terminated |
Study Name: "Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunodeficiency Condition: Common Variable Immunodeficiency Date: 2011-12-08 Interventions:
|
Completed |
Study Name: Immune System and Gut Abnormalities in Patients With Common Variable Immunodeficiency With and Without Gastrointestinal Symptoms Condition: Common Variable Immunodeficiency Date: 2001-04-18 |
Completed |
Study Name: STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency Condition: Common Variable Immunodeficiency Date: 2005-12-07 Interventions: Drug: STA-5326 |
Completed |
Study Name: Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency Condition: Common Variable Immunodeficiency Date: 2000-02-24 Interventions: Drug: PEG-interleukin-2 |
Completed |
Study Name: The Rifaximin Study in CVID Condition: Common Variable Immunodeficiency (CVID) Date: 2013-09-12 Interventions: Drug: Rifaximin Other Name: Xifaxan |
Completed |
Study Name: Specific IgG Antibody in Patients With Primary Antibody Deficiencies Treated With Subcutaneous Immunoglobulin Condition:
Date: 2008-04-14 Interventions: Biological: gammaglobulin They were administered a polyvalent, pasteurized liquid immune globulin subcut |
Completed |
Study Name: Lymphocyte Immunophenotyping in Common Variable Immunodeficiency Condition:
|
Not yet recruiting |
Study Name: Improving the Diagnosis of Common Variable Immune Deficiency Condition: Common Variable Immune Deficiency (CVID) Date: 2016-02-08 |
Recruiting |
Study Name: Immune Regulation in Patients With Common Variable Immunodeficiency and Related Syndromes Condition: CVID Date: 1999-11-03 |
Completed |
Study Name: A Multi-centre Open Study to Assess the Safety and Efficacy of Subgam® Condition: Primary Antibody Deficiency. Date: 2014-09-02 Interventions: Biological: Subgam® (Human Normal Immunoglobulin Solution) |